AU2002246135A1 - Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase - Google Patents

Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase

Info

Publication number
AU2002246135A1
AU2002246135A1 AU2002246135A AU2002246135A AU2002246135A1 AU 2002246135 A1 AU2002246135 A1 AU 2002246135A1 AU 2002246135 A AU2002246135 A AU 2002246135A AU 2002246135 A AU2002246135 A AU 2002246135A AU 2002246135 A1 AU2002246135 A1 AU 2002246135A1
Authority
AU
Australia
Prior art keywords
selectins
isoform
inducible
inhibitors
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002246135A
Inventor
Jesus Lopez-Belmonte Pascual
Juan Lopez-Belmonte Pascual
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bobel 246 SL
Original Assignee
Bobel 246 SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bobel 246 SL filed Critical Bobel 246 SL
Publication of AU2002246135A1 publication Critical patent/AU2002246135A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002246135A 2002-03-14 2002-03-14 Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase Abandoned AU2002246135A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2002/000119 WO2003075905A1 (en) 2002-03-14 2002-03-14 Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase

Publications (1)

Publication Number Publication Date
AU2002246135A1 true AU2002246135A1 (en) 2003-09-22

Family

ID=27799019

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002246135A Abandoned AU2002246135A1 (en) 2002-03-14 2002-03-14 Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase

Country Status (2)

Country Link
AU (1) AU2002246135A1 (en)
WO (1) WO2003075905A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764096A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
ES2258415B2 (en) * 2006-04-12 2007-05-01 Fundacion Universitaria San Pablo Ceu BOBEL-24 (2,4,6-TRYODOPHENOL) FOR THE TREATMENT OR PREVENTION OF HUMAN AND ANIMAL CRYPTOSPORIDIOSIS.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU576340B2 (en) * 1983-12-16 1988-08-25 Bislak S.A. Therapeutic applications of 2,4,6-triiodophenol
ATE204478T1 (en) * 1993-05-03 2001-09-15 Genentech Inc INHIBITION OF LEUKOCYTE ADHESION
ES2087019B1 (en) * 1994-02-08 1997-03-16 Bobel246 S L USE OF DERIVATIVES OF PHENOLS 2,4-DISUBSTITUTED AS INHIBITORS OF 5-LIPOXIGENASE.
AU5317296A (en) * 1995-03-24 1996-10-16 Francis V. Defeudis Methods for treating conditions associated with excess nitri c oxide

Also Published As

Publication number Publication date
WO2003075905A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
HK1078603A1 (en) Use of moo3 as corrosion inhibitor, and coating composition containing such an inhibitor
AU2003257666A1 (en) COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
MXPA03007049A (en) Heterocyclic inhibitors of erk2 and uses thereof.
HUP0402629A3 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AU2002228317A1 (en) Benz-1,3-azole derivatives and their uses as heparanase inhibitors
AU2003219100A1 (en) Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3
WO2004052236A3 (en) Methods and compositions for treatment of otitis media
AU2003290799A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2002017919A3 (en) Use of threo-methylphenidate compounds to enhance memory
HUP0101899A3 (en) Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes, pharmaceutical compositions comprising thereof and their use
AU2002246135A1 (en) Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase
ZA200502909B (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2.
AU2002358874A1 (en) 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
AU2002246983A1 (en) 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
RS20060206A (en) Aminopyridine-derivatives as inducible no-synthase inhibitors
WO2001070233A3 (en) Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
SI1532141T1 (en) 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS
WO2004056832A3 (en) Epothilone derivatives
AU2003304240A1 (en) INHIBITION OF EGR-1 EXPRESSION BY RPAR-Gamma AGONISTA AND RELATED COMPOSITIONS AND METHODS
WO2004028541A3 (en) Composition for the treatment of nasopharyngeal carcinoma and use thereof
WO2001024784A3 (en) New use
AU2002355706A1 (en) Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase